Overview Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema Status: Completed Trial end date: 2021-02-24 Target enrollment: Participant gender: Summary This study will assess the safety and efficacy of ARQ-252 cream in subjects with chronic hand eczema Phase: Phase 1/Phase 2 Details Lead Sponsor: Arcutis Biotherapeutics, Inc.